Login

Dareczka Wasowicz-Kemps

ORCID: 0000-0002-6764-0219
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5013095103
Research Areas
  • Gastric Cancer Management and Outcomes
  • Colorectal Cancer Treatments and Studies
  • Anorectal Disease Treatments and Outcomes
  • Colorectal and Anal Carcinomas
  • Diverticular Disease and Complications
  • Multiple and Secondary Primary Cancers
  • Pelvic floor disorders treatments
  • Colorectal Cancer Surgical Treatments

Elisabeth-TweeSteden Ziekenhuis
 2023-2024

 Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR‐TREC)? Protocol for the international, multicentre, rolling phase II/III partially randomized patient preference trial evaluating long‐course concurrent chemoradiotherapy versus short‐course radiotherapy organ preservation approaches
OPENALEX - Publications 
Simon P. Bach David Sebag‐Montefiore H Dewilt Kl Garm‐spindler Corrie A.M. Marijnen and 95 more Femke P. Peters Peter Christensen Alexandra Gilbert Mark Teo Ane Appelt Nicholas P. West Victoria Homer Simon Gates Niki Christou Karin Haustermans Albert Wolthuis Annelies Debucquoy Anna Martling Eva Angenete Peter Lind Ruth H. Keogh Leyre Navarro‐Núñez Gunnar Baatrup Issam Al‐Najami Irıs D. Nagtegaal Cl Andersen Ian Tomlinson Andrew D. Beggs Remond J.A. Fijneman Marjolijn J. L. Ligtenberg James Hill Nicola Fearnhead S. Körsgen Ian Geh Philip Quirke Nick Abbott Ann Russell Colm Forde Arvind Pallan M. Hawkins Mg Guren Dale Vimalchandran Matthew J. Lee Chris Hurt Alexander Mirnezami Louise Hiller A.S. Dhadda Sophia Magwaro Gillian M. Nixon Manjinder Kaur Fan Shi I Nutt George Smith Susie Mee K. James J Keely Hans De Wilt Nynke G. Greijdanus Audrey De Jong Louis Smets Heidi Rütten James Good Julian Hance Alex Gilber Fabian A. Holman Laura A. Velema Per Pfeiffer Dibyendu Bandyopadhyay Nathalie Casanova GL Beets Matthew G. Tutton Sadaf Usman Karen‐Lise Garm Spindler Jeroen W. A. Leijtens Maaike Berbée Sandeep Kapur Debashis Biswas Atanu Pal J.M Wheeler Rashmi Jardon Noreem Alam Mark Steward Paul Hatfield A ten Tije Rhph Crolla Gp van Der Schelling Chris Cunningham C. Jacobs Stephen Boyce Erik van Westreenen O. Reerink Kathryn Mccarthy Stephen Falk Dareczka Wasowicz-Kemps R.L. Poorter D. D. E. Zimmerman Michael Davies Richard Adams Apollo Pronk Martijn Intven

Abstract Aim Organ‐saving treatment for early‐stage rectal cancer can reduce patient‐reported side effects compared to standard total mesorectal excision (TME) and preserve quality of life. An optimal strategy achieving organ preservation longer‐term oncological outcomes are unknown; thus there is a need high trials. Method Can we S ave the rectum by watchful waiting or T rans A nal surgery following (chemo) R adiotherapy versus otal early RE ctal C ancer (STAR‐TREC) an international...

10.1111/codi.16056 article EN cc-by Colorectal Disease 2022-02-03
 Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment
OPENALEX - Publications 
Dave E. W. van der Kruijssen Sjoerd G. Elias Geraldine R. Vink Karlijn L. van Rooijen Jorine ‘t Lam-Boer and 88 more Linda Mol Cornelis J.A. Punt Johannes H.W. de Wilt Miriam Koopman Gijs J.D. van Acker Rahim Altaf Kees van Arkel Coen I.M. Baeten Sandra D. Bakker Frank C. den Boer Marien O. den Boer K. Bosscha Edwin A. van Breugel Rebecca P. M. Brosens Huib A. Cense Esther C. J. Consten Geert‐Jan Creemers Hester van Cruijsen Wendy M. van der Deure Joyce M. van Dodewaard Anne-Lene G. Fromm A. J. Gelderblom Michael F. Gerhards Marie-José de Gier Eelco J. R. de Graaf Wilhelmina M. U. van Grevenstein Jan Willem B. de Groot Brigitte C.M. Haberkorn Jamal Oulad Hadj Paul Hamberg Erwin van der Harst Helgi H. Helgason Mathijs P. Hendriks Daniël A. Hess Ignace H. J. T. de Hingh Ronald Hoekstra Joost A.B. van der Hoeven M.J. van Hoogstraten Henrik Jakobsen Felix E. de Jongh Emile D. Kerver Monica L Kjaer Bart C. Kuenen Philomeen Kuijer Sophie A. Kurk Wouter K. G. Leclercq Lobke L. van Leeuwen-Snoeks Jeroen W. A. Leijtens Gábor Liposits O. J. L. Loosveld Martijn F. Lutke Holzik Peter Nieboer Jesper Dan Nielsen Koen Peeters Lone N. Petersen Apollo Pronk Bareld B. Pultrum Koen Reijnders J.M.G.H. van Riel Ron C. Rietbroek George P. van der Schelling Wilhelmina H. Schreurs Nis Hallundbæk Schlesinger Heidi Schut Michael Seiersen Lieke H. J. Simkens Dirkje W. Sommeijer Pieter J. Tanis Mehmet Temizkan Marc W. A. van Tilburg Marija Trajkovic Anthony W. H. van de Ven Henk M.W. Verheul Mareille Verseveld Jeroen Vincent Wouter J. Vles F. Jeroen Vogelaar Aad I. de Vos Allert H. Vos Ronald J.C.L.M. Vuylsteke Wim Bleeker Dareczka Wasowicz-Kemps Johannes A. Wegdam Henderik L. van Westreenen Louise M. de Widt-Levert Agnès J. van de Wouw Mette Yilmaz Peter van Duijvendijk

<h3>Importance</h3> The role of primary tumor resection (PTR) in synchronous patients with metastatic colorectal cancer (mCRC) who had unresectable metastases and few or absent symptoms their is unclear. Studying subgroups low postoperative mortality may identify potentially benefit from PTR. <h3>Objective</h3> To determine the difference 60-day between randomized to systemic treatment only vs PTR followed by treatment, explore risk factors associated mortality. <h3>Design, Setting,...

10.1001/jamasurg.2021.4992 article EN JAMA Surgery 2021-10-09
 Upfront palliative resection of primary tumor versus no resection in patients with synchronous metastatic colorectal cancer: The randomized phase 3 CAIRO4 study of the Dutch Colorectal Cancer Group (DCCG).
OPENALEX - Publications 
Miriam Koopman Dave E. W. van der Kruijssen Sjoerd G. Elias Peter M. van de Ven Linda Mol and 15 more Cornelis J.A. Punt Pieter J. Tanis Jesper Dan Nielsen Mette Yilmaz O. J. L. Loosveld George P. van der Schelling Dareczka Wasowicz-Kemps J.M.G.H. van Riel Mareille Verseveld Paul Hamberg Henrik Jakobsen Anna-Lene Fromm Henderik L. van Westreenen Jan Willem de Groot Johannes H.W. de Wilt

3517 Background: Primary tumor resection (PTR) in patients with synchronous metastatic colorectal cancer (CRC) has been associated a survival benefit comparative cohort studies. In the CAIRO4 phase III randomized trial, potential of upfront PTR followed by systemic therapy versus alone was investigated. Methods: Main eligibility criteria included histologically confirmed CRC, unresectable metastases, resectable primary situ without related severe symptoms, and WHO performance status (PS)...

10.1200/jco.2023.41.16_suppl.3517 article EN Journal of Clinical Oncology 2023-06-01
 Ligation of intersphincteric fistula tract (LIFT) for trans-sphincteric cryptoglandular anal fistula: long-term impact on faecal continence
OPENALEX - Publications 
Justin Y. van Oostendorp C. Verkade Ingrid J. M. Han‐Geurts Grietje J. H. van der Mijnsbrugge Dareczka Wasowicz-Kemps and 1 more D. D. E. Zimmerman

The ligation of intersphincteric fistula tract is a surgical technique designed to treat trans-sphincteric anal fistulas aiming preserve sphincter integrity. Recent studies suggest its efficacy in short-term healing with limited impact on continence. However, comprehensive prospective data long-term outcomes, including recurrence and bowel continence, are limited. present study aims report the functional outcomes.

10.1093/bjsopen/zrae055 article EN cc-by-nc BJS Open 2024-05-08
Coming Soon ...